741231491	741231491	CD	B-NP	O
|	|	NN	I-NP	O
BH	BH	NN	I-NP	O
|	|	NN	I-NP	O
62990263	62990263	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
954537	954537	CD	B-NP	O
|	|	CC	I-NP	O
7/23/1995	7/23/1995	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/22/1995	3/22/1995	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/18/1995	5/18/1995	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
RIGHT	RIGHT	NN	B-NP	O
BREAST	BREAST	NN	I-NP	O
ABSCESS	ABSCESS	NN	I-NP	O
.	.	.	O	O

SIGNIFICANT	SIGNIFICANT	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
OBESITY	OBESITY	NNP	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
DEPRESSION	DEPRESSION	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HYPERTENSION	HYPERTENSION	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57	57	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Haggard	Haggard	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IWAKE	IWAKE	NNP	I-NP	O
HEALTHCARE	HEALTHCARE	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
for	for	IN	B-PP	O
problems	problem	NNS	B-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
and	and	CC	O	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1994	1994	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
breast	breast	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
mammogram	mammogram	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
mildly	mildly	RB	B-NP	O
dense	dense	JJ	I-NP	O
parenchyma	parenchyma	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
calcium	calcium	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
4	4	CD	B-NP	O
mm	mm	NN	I-NP	O
hypoechoic	hypoechoic	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
compatible	compatible	JJ	I-NP	O
duct	duct	NN	I-NP	O
obstruction	obstruction	NN	I-NP	O
with	with	IN	B-PP	O
debris	debris	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
breast	breast	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
waxed	wax	VBD	B-VP	O
and	and	CC	I-VP	O
waned	wan	VBD	I-VP	O
and	and	CC	O	O
follow-up	follow-up	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
of	of	IN	B-PP	O
1994	1994	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
X	X	SYM	I-NP	O
0.5	0.5	CD	I-NP	O
cm	cm	NN	I-NP	O
mass	mass	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
advise	advise	NN	B-NP	O
to	to	TO	B-VP	O
return	return	VB	I-VP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
months	month	NNS	I-NP	O
for	for	IN	B-PP	O
repeat	repeat	NN	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
and	and	CC	I-NP	O
aspiration	aspiration	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1995	1995	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
indurated	indurated	JJ	I-NP	O
area	area	NN	I-NP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
breast	breast	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Noguchi	Noguchi	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Surgery	Surgery	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
and	and	CC	O	O
scheduled	schedule	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
breast	breast	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
persistent	persistent	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
breast	breast	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1995	1995	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hypertension	Hypertension	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Obesity	Obesity	NNP	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Tobacco	Tobacco	NNP	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Depression	Depression	NNP	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Uterine	Uterine	NN	I-NP	O
leiomyoma	leiomyoma	NN	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Polymyalgia	Polymyalgia	NNP	I-NP	O
rheumatica	rheumatica	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diltiazem	Diltiazem	NNP	I-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
divorced	divorce	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
and	and	CC	O	O
denies	deny	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
cerebral	cerebral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
170/110	170/110	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
80	80	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pupils	pupil	NNS	I-NP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Discs	Disc	NNS	B-NP	O
are	be	VBP	B-VP	O
sharp	sharp	JJ	B-ADJP	O
and	and	CC	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
narrowed	narrow	VBN	I-VP	O
vessels	vessel	NNS	B-NP	O
on	on	IN	B-PP	O
fundoscopic	fundoscopic	JJ	B-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
breast	breast	NN	I-NP	O
shows	show	VBZ	B-VP	O
indurated	indurate	VBN	I-VP	O
2	2	CD	B-NP	O
X	X	SYM	I-NP	O
3	3	CD	I-NP	O
cm	cm	NN	I-NP	O
mass	mass	NN	I-NP	O
just	just	RB	B-PP	O
above	above	IN	I-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
nipple	nipple	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
overlying	overlie	VBG	I-NP	O
erythema	erythema	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
moderately	moderately	RB	B-ADVP	O
tender	tender	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
examination	examination	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
and	and	CC	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
six	six	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBD	B-VP	O
best	well	RBS	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
midline	midline	NN	I-NP	O
scar	scar	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
diminished	diminish	VBN	I-VP	O
peripheral	peripheral	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neurological	neurological	JJ	I-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
shows	show	VBZ	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
EKG	EKG	NNP	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
General	General	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
more	more	RBR	B-NP	O
aggressive	aggressive	JJ	I-NP	O
hypertensive	hypertensive	JJ	I-NP	O
medications	medication	NNS	I-NP	O
including	include	VBG	B-PP	O
increasing	increase	VBG	B-VP	O
her	her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
to	to	TO	B-PP	O
Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
discontinuing	discontinue	VBG	B-VP	O
her	her	PRP$	B-NP	O
Diltiazem	Diltiazem	NN	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
Hydrochlorothiazide	Hydrochlorothiazide	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.	q.	FW	I-ADVP	O
daily	daily	RB	I-ADVP	O
and	and	CC	O	O
starting	start	VBG	B-VP	O
Beta	Beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
as	as	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
surgery	surgery	NN	B-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1995	1995	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
breast	breast	NN	I-NP	O
abscess	abscess	NN	I-NP	O
was	be	VBD	B-VP	O
drained	drain	VBN	I-VP	O
without	without	IN	B-PP	O
incident	incident	NN	B-NP	O
.	.	.	O	O

Post	Post	NNP	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
which	which	WDT	B-NP	O
included	include	VBD	B-VP	O
Ancef	Ancef	NN	B-NP	O
1	1	CD	I-NP	O
gram	gram	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
notable	notable	JJ	I-NP	O
events	event	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
Psychiatry	Psychiatry	NNP	I-NP	O
consult	consult	NN	I-NP	O
who	who	WP	B-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
major	major	JJ	B-NP	O
depression	depression	NN	I-NP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
ruling	rule	VBG	I-VP	O
organic	organic	JJ	B-NP	O
brain	brain	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
polysonography	polysonography	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
for	for	IN	B-PP	O
monitoring	monitoring	NN	B-NP	O
of	of	IN	B-PP	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
MMTI	MMTI	NN	I-NP	B-DNA
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
uneventful	uneventful	JJ	I-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
remaining	remain	VBG	B-VP	O
moderately	moderately	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
and	and	CC	I-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
breast	breast	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Zonhend	Zonhend	NNP	I-NP	O
Manggu	Manggu	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Surgical	Surgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
and	and	CC	O	O
Cephradine	Cephradine	NN	B-NP	O
with	with	IN	B-PP	O
follow-up	follow-up	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
TLET	TLET	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mcgowan	Mcgowan	NNP	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Hmotmed	Hmotmed	NNP	I-NP	O
Dell	Dell	NNP	I-NP	O
An	An	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Enteric	Enteric	JJ	I-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Colace	Colace	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Hydrochlorothiazide	Hydrochlorothiazide	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Tylox	Tylox	NN	I-NP	O
1-2	1-2	CD	B-NP	O
capsules	capsule	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	NN	I-NP	O
4-6h	4-6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Atenolol	Atenolol	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Cephradine	Cephradine	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
times	time	NNS	I-NP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
BURL	BURL	NNP	B-NP	O
G.	G.	NNP	I-NP	O
NORLUND	NORLUND	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
/	/	SYM	B-NP	B-protein
D.PHIL	D.PHIL	NN	I-NP	I-protein
YH8	YH8	NN	I-NP	I-protein
Attending	Attend	VBG	B-VP	O
:	:	:	O	O
EDMUNDO	EDMUNDO	NNP	B-NP	O
Z.	Z.	NNP	I-NP	O
VARGO	VARGO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
EZ34	EZ34	NNP	I-NP	O
EX809/5240	EX809/5240	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
04881	04881	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

XNAQXA5AB	XNAQXA5AB	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
:	:	:	O	O
8/10/96	8/10/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/17/96	8/17/96	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
LENARD	LENARD	NNP	B-NP	O
A.	A.	NNP	I-NP	O
PLUMLEE	PLUMLEE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TU94	TU94	NNP	I-NP	O
WILBURN	WILBURN	NNP	I-NP	O
I.	I.	NNP	I-NP	O
UXA	UXA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ZJ59	ZJ59	.	O	B-DNA

